The shareholders of the two companies announced that they would reduce their holdings at the expiration of the one-year sale period

On May 22, a number of listed companies disclosed the reduction announcement.

among them, the reduction of shareholders of Allgens Medical Technology Co.Ltd(688613) ( Allgens Medical Technology Co.Ltd(688613) ) and Nanjing Shenghang Shipping Co.Ltd(001205) ( Nanjing Shenghang Shipping Co.Ltd(001205) ) are the shares obtained before the IPO, which has just been lifted in May

reduced holdings upon expiration of sales restriction

On May 22, Allgens Medical Technology Co.Ltd(688613) announced that the company’s shareholders Beijing Qilun Tianyou Venture Capital Co., Ltd. (hereinafter referred to as “Qilun Tianyou”), bioveda China RMB investment Limited (hereinafter referred to as “bioveda”), Jiaxing Huakong equity investment fund partnership (limited partnership) (hereinafter referred to as “Jiaxing Huakong”) would reduce their holdings through centralized bidding and block trading according to market conditions due to their own capital arrangements.

as of the disclosure date of the announcement, the proportion of the three shareholders in Allgens Medical Technology Co.Ltd(688613) total shares was 9.07%, 8.82% and 9.73% respectively, and the proportion of shares to be reduced this time was no more than 2.69%, 3% and 4.87%

Allgens Medical Technology Co.Ltd(688613) 2021 landed in the capital market on May 21, and the above shares are the shares obtained by Qilun Tianyou, bioveda and Jiaxing Huakong before the initial public offering and listing of the company, which have been listed and circulated since May 23, 2022. 3. The previous commitment made by the shareholders to restrict and lock up the circulation of shares is not to transfer or entrust others to manage the shares held by the company before the public offering of shares within 12 months from the date of listing of the company’s shares, nor will the company buy back such shares.

as a national high-tech enterprise focusing on the R & D, production and sales of high-end biomedical materials and related medical devices, Allgens Medical Technology Co.Ltd(688613) was popular in the capital market at the beginning of its listing, and the company’s share price reached a high of 137.85 yuan / share on June 1, 2021. However, since then, the company’s share price has gradually declined, closing at 29.69 yuan / share on May 20

Similarly, Nanjing Shenghang Shipping Co.Ltd(001205) .

may 22 Nanjing Shenghang Shipping Co.Ltd(001205) announcement, the shareholder the Belt and Road Investment Fund (limited partnership) (hereinafter referred to as “the Belt and Road fund”) holds 7.08% of the total share capital of the company due to its own business needs, the the Belt and Road fund plans to reduce its total shares of the company by block trading within 6 months after 15 trading days from the date of disclosure of the announcement, and within 6 months after 3 trading days from the date of disclosure of the announcement, not more than 5% of the total share capital.

The reduction of the the Belt and Road fund is also the company’s shares held by Nanjing Shenghang Shipping Co.Ltd(001205) .

Nanjing Shenghang Shipping Co.Ltd(001205) landed in the capital market on May 13, 2021. On May 10, 2022, the company issued a suggestive announcement on the lifting of restrictions on the sale and listing of some of the shares issued before the initial public offering

After that, on May 17 Nanjing Shenghang Shipping Co.Ltd(001205) it was disclosed that Nanjing Yida Huisheng venture capital fund (limited partnership), Jiangsu modern service industry development venture capital fund (limited partnership) and Jiangsu talent innovation venture capital phase III Fund (limited partnership), the shareholders holding more than 5% of the company’s shares in total, planned that within 6 months after 15 trading days from the date of disclosure of this announcement, The total reduction of shares of the listed company by means of centralized bidding trading shall not exceed 2% of the total share capital of the company.

l capital holding Guangdong Marubi Biotechnology Co.Ltd(603983) decreased to less than 5%

On May 22, Guangdong Marubi Biotechnology Co.Ltd(603983) ( Guangdong Marubi Biotechnology Co.Ltd(603983) ) announced that the company received the short form equity change report sent by L capital Guangzhou beauty Ltd. (hereinafter referred to as “l capital”), a shareholder holding more than 5% shares. L capital reduced Guangdong Marubi Biotechnology Co.Ltd(603983) 6908300 shares on May 20, accounting for 1.72% of the total share capital of the listed company.

before the equity change, l capital held about 6.72% of the total share capital. After this equity change, l capital holds about 4.99% of the total share capital, and l capital is no longer a shareholder of Guangdong Marubi Biotechnology Co.Ltd(603983) holding more than 5%

It is disclosed that l Capital Asia, LLC is a professional private equity investment institution. L capital is the main body established by L Capital Asia, LLC to invest in Guangdong Marubi Biotechnology Co.Ltd(603983) and took shares in Guangdong Marubi Biotechnology Co.Ltd(603983) in May 2013. It has been nine years since then. During this period, l capital has established a friendly and mutually trusted cooperative relationship and has always been optimistic about the development and future of Guangdong Marubi Biotechnology Co.Ltd(603983) .

For this reduction, Guangdong Marubi Biotechnology Co.Ltd(603983) said that it was because l capital held Guangdong Marubi Biotechnology Co.Ltd(603983) shares for a long time, and as an equity investment company, it had its own capital exit demand.

After was listed in 2019, Guangdong Marubi Biotechnology Co.Ltd(603983) share price once strengthened, approaching 100 yuan per share. However, since May 2020, under the overall decline of performance, the company’s share price has also dropped significantly, falling below 20 yuan / share at the end of April this year

Qianjiang Water Resources Development Co; Ltd(600283) ( Qianjiang Water Resources Development Co; Ltd(600283) ) was also reduced.

Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) ( Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) ) on May 22, it was disclosed that the company planned to reduce its Qianjiang Water Resources Development Co; Ltd(600283) no more than 352996 million shares held by Qianjiang Water Resources Development Co; Ltd(600283) through centralized bidding trading in Shanghai Stock Exchange, accounting for no more than 10% of Qianjiang Water Resources Development Co; Ltd(600283) total share capital, and the implementation period was the fiscal year since the approval of the board of directors of the company.

As of the first quarterly report of 2022, Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) is the second largest shareholder of Qianjiang Water Resources Development Co; Ltd(600283) with a shareholding ratio of 12.2%. The above shares were acquired by Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) in the shares of the latter before its initial public offering, participation in private placement subscription and centralized bidding transaction in the secondary market.

Regarding the disclosed reduction plan, Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) said that the company has long been firmly optimistic about the future development of Qianjiang Water Resources Development Co; Ltd(600283) and the development prospect of its industry. The reduction of Qianjiang Water Resources Development Co; Ltd(600283) shares is only based on the actual operation needs of the company, optimizes the asset structure of the company, improves the operating efficiency, and does not affect the company’s position as the main shareholder of Qianjiang Water Resources Development Co; Ltd(600283) in this time.

at present, the tender offer of Qianjiang Water Resources Development Co; Ltd(600283) by China Power Construction Group Co., Ltd. (hereinafter referred to as “Power Construction Group”) is being promoted

According to the announcement of Qianjiang Water Resources Development Co; Ltd(600283) may 21, power construction group plans to obtain the control right of China Water Investment Co., Ltd. through the combination of equity transfer and accepting the entrustment of shareholders’ rights, so that the indirect ownership of Qianjiang Water Resources Development Co; Ltd(600283) through China Water Investment Co., Ltd. will exceed 30% of its issued shares. This transaction has been submitted to the state owned assets supervision and Administration Commission of the State Council for approval and is currently in the process of approvalcenter>

- Advertisment -